Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 3, 2009, Pages 422-426

  Potard, Valérie ^a,b   Weiss, Laurence ^c   Lamontagne, Franck ^d   Rouveix, Elisabeth ^c   Beck Wirth, Geneviève ^e   Drogoul Vey, Marie Pierre ^f   Souala, Mohamed Faouzi ^g   Costagliola, Dominique ^a,h  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d Solthis   (France)

^e CENTRE HOSPITALIER DE MULHOUSE   (France)

^f HÔPITAL SAINTE MARGUERITE   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CD4 cell count; Cohort; HIV 1 primary infection; Viral load

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; PRIMARY INFECTION; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; TIME FACTORS; VIRAL LOAD;

EID: 70350543854     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181ab6ec1     Document Type: Article

References (14)

1. O'Brien TR, Hoover DR, Rosenberg P, et al. Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion. Am J Epidemiol. 1995;142:636-642.
2. Holmberg SD, Conley LJ, Luby SP, et al. Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:291-296.
3. Galai N, Lepri AC, Vlahov D, et al. Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The human immunodeficiency virus Italian seroconversion study. Am J Epidemiol. 1996;143:278-282.
4. Vanhems P, Lambert J, Guerra M, et al. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV Cohort Study. J Infect Dis. 1999;180:1803-1808.
5. Dorrucci M, Phillips AN, Longo B, et al. Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002. Italian HIV-Seroconversion Study. AIDS. 2005;19:331-335.
6. Dorrucci M, Rezza G, Porter K, et al. Temporal trends in postser-oconversion CD4 cell count and viral load: the concerted action on seroconversion to AIDS and death in Europe collaboration, 1985-2002. J Infect Dis. 2007;195:525-534.
7. Lievre L, Deveau C, Gerbe J, et al. Yearly number of patients diagnosis with primary HIV-1 infection in France estimated by a capture-recapture approach. AIDS. 2006;20:2392-2394.
8. Rapport 2006 sous la direction du Pr P Yeni. Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d'experts. [Report under the direction of Professor P Yeni. Therapeutic care for individuals infected by HIV. Recommendations of a group of experts]. Paris, France: Médecine-Sciences Flammarion 2006.
9. Rouzioux C, Potard V, Burgard M, et al. The French HIV-RNA quantification quality controls performed yearly from 1997 show important variations of two commercial kits over time [MoPe15.1C12]. Presented at: 3rd IAS Conference on HIV pathogenesis and treatment; July 24-27, 2005; Rio de Janeiro, Brazil.
10. Sagar M, Lavreys L, Baeten JM, et al. Infection with multiple HIV-1 variants is associated with faster disease progression. J Virol. 2003;77: 12921-12926.
11. Chaix ML, Descamps D, Harzic M, et al. Stable prevalence of geno-typic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS. 2003;17: 2635-2643.
12. Descamps D, Chaix ML, André P, et al. French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-näive chronically infected patients in 2001-2002. J Acquir Immune Defic Syndr. 2005;38:545-552.
13. Grant RM, Hecht FM, Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002;288: 181-188.
14. Chaix ML, Fichou J, Deveau C, et al. Stable frequency of HIV-1 transmitted drug resistance over a decade (1996-2006) in France is likely explained by the increase of chronically treated patients in virological success? [42; Antivir Ther. 2007;12:S49]. Presented at: XVI International HIV Drug Resistance Workshop; June 12-16, 2007; Barbados.